A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance

Despite significant advances in the treatment of hepatitis C virus (HCV) infection, the need to develop preventative vaccines remains. Identification of the best vaccine candidates and evaluation of their performance in preclinical and clinical development will require appropriate neutralization ass...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Virol
Главные авторы: Urbanowicz, Richard A., McClure, C. Patrick, Brown, Richard J. P., Tsoleridis, Theocharis, Persson, Mats A. A., Krey, Thomas, Irving, William L., Ball, Jonathan K., Tarr, Alexander W.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2016
Предметы:
Vaccines and Antiviral Agents
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794667/
https://ncbi.nlm.nih.gov/pubmed/26699643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02700-15
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы